corynebacterium diphtheria

CorynebacteriumCorynebacteriumDiphtheria Diphtheria

Dr.T.V.Rao MD.Dr.T.V.Rao MD.

Dr.T.V.Rao MD 1

Diphtheria

• Greek diphtheria (leather hide)

• Caused by Aerobic Gram +ve rods

• Corynebacterium diphtheria

• Exotoxin production only if infected by virus phage infected carrying toxin gene

Dr.T.V.Rao MD 2

CorynebacteriumCorynebacterium• Gram + Non Acid fast, Non motile,

• Irregularly stained with granules,

• Club shaped swelling at one or both ends so the name

• Important Pathogen

Corynebacterium diphtheria,

Diptheros meaning leather,

Dr.T.V.Rao MD 3

What is Diphtheria• An infection of

local tissue of URT with production of toxin which causes systemic effects on Heart and Peripheral tissues,

Dr.T.V.Rao MD 4

5

DefinitionDefinition

• Diphtheria is an acute, toxin-mediated disease caused by toxigenic Corynebacterium diphtheria.

• It’s a very contagious and potentially life-threatening bacterial disease.

Dr.T.V.Rao MD

6

Definition • It’s a localized infectious disease,

which usually attacks the throat and nose mucous membrane

Dr.T.V.Rao MD

7

Etiology

• C. diphtheriae is an aerobic gram-positive bacillus.

–Pleomorphic, club-end–Non-spore-forming–Non-acid-fast–Non-motile

Dr.T.V.Rao MD

8

Etiology• The major virulence determinant is

an exotoxin, diphtheria toxin. After binding to the host cells, the active subunit will interrupt the protein synthesis of the target host cell and results in cell death.

• Toxoid made from diphtheria toxin can be used as vaccine.

Dr.T.V.Rao MD

9

Etiology• There are three biotypes —

gravis, Intermedius, and mitis. The most severe clinical type of this disease is associated with the gravis biotype, but any strain may produce toxin.

Dr.T.V.Rao MD

Pathogenesis • Entry ------ the bacilli multiply locally in the

throat and elaborate a powerful exotoxin ----- produce local and systemic symptoms.

Local lesions : • Exotoxin causes necrosis of the epithelial cells

and liberates serous and fibrinous material which forms a grayish white pseudo membrane

• The membrane bleeds on being dislodged• Surrounding tissue is inflamed and edematous

Dr.T.V.Rao MD 10

Fauces ( throat )

Fauces : - two pillars of mucous membrane. Anterior : known as the palatoglossal arch and Posterior : the palatopharyngeal archBetween these two arches is the palatine tonsil.

Dr.T.V.Rao MD 11

Typical Presentation of Bull Neck

Dr.T.V.Rao MD 12

Local manifestation Local manifestation

Depend on the site of lesion:

Nasal diphtheria : • Unilateral or bilateral

serosanguineous ( blood and serous fluid ) discharge from the nose

• Excoriation of upper lip • Toxemia is minimal

Faucial diphtheria : • Redness and swelling

over Fauces• Exudates on the

tonsils coalesces to form grayish white pseudo membrane

• Regional lymph nodes are inflamed

• Sore throat and • dysphagia

Dr.T.V.Rao MD 13

Dr.T.V.Rao MD 14

Corynebacterium diphtheriaCorynebacterium diphtheria

• Slender rods• Clubbing at both ends• Pleomorphic• Non capsulate / Acid fast Gram +• Granules are composed of

polymetapohosphate• Staining with Loffler's methylene blue

show bluish purple metachromatic granules. with polar bodies,

Dr.T.V.Rao MD 15

Dr.T.V.Rao MD 16

Staining methods• Grams method• Albert's stain

• Neissers stain

• Ponders stain

• On staining seen as

Pairs, Appear as v and L letters, resembling Chinese letter pattern or also called cuneiform arrangement.

Dr.T.V.Rao MD 17

Cultural charactersCultural characters• Need enrichment Media

• Contain

• Blood, Serum or Egg 37 c ph 7.4

• Aerobic/Facultative anaerobic.

• Commonly used medium

• Loeffler serum slope,

• Tellurite Blood agar,

Dr.T.V.Rao MD 18

Gram +ve Bacilli and Colonies

Dr.T.V.Rao MD 19

• Selective & differential medium

• Corynebacterium are resistant to tellurite– Reduced to tellurium

• Forms deposit in colonies– Colonies appear dark

• Biotypes– gravis, Intermedius, mitis

Dr.T.V.Rao MD 20

Culturing Culturing

Growing on Culture Plates• Loffler serum slope Grows rapidly in

6 -8 hours, Small white

opaque disks Turns to yellow Tellurite blood agar

Modified Mac Leod

Hoyles medium.Dr.T.V.Rao MD 21

Commonly used medium

• Tellurite blood agar Contains tellurite 0.04 tellurite Inhibits other bacteria

• Produce Grey/Black colonies.

Dr.T.V.Rao MD 22

Classification of McLeodClassified in to 3 Types1 Gravis2 Intermedius3.MitisGravis produce Most serious Hemorrhagic Paralytic complications - Epidemic Intermedius Hemorrhagic Mitis - obstructive complications, Endemic Geographic locations differTesting for toxigenicity is more important,

Dr.T.V.Rao MD 23

Biochemical ReactionsBiochemical Reactions

• Acid

Glucose,Galactose Maltose, Dextrin

Do not produce acid withDo not produce acid with Lactose, Mannitol, sucrose.All fermentation reactions tested in Hiss serum sugarsUrease test negative.Proteolytic

Dr.T.V.Rao MD 24

Toxin Toxin • Pathogenicity associated with Toxin• Gravis/Intermedius 95-99% are

toxigenic• Mitis 80 – 85% • Some abundant others poorly• Toxin production park William 8• Toxin M W 62,000 0.0001 can kill guinea pig

Dr.T.V.Rao MD 25

Diphtheria toxin: Part A

• Active site• Enzyme

• Blocks protein synthesis– ADP-ribosyl transferase– elongation factor 2 (EF2)

• Specific for mammalian cells– Prokaryotes have different EF2

Dr.T.V.Rao MD 26

Diphtheria Toxin: Part BDiphtheria Toxin: Part B• Binding Site• Binds to cell receptor• Bound receptor

internalized• Endosome

– Hydrolyzed by protease

– Disulfide broken– Part A released

Dr.T.V.Rao MD 27

Activation of Diphtheria Toxin

A

A

B

B

A

B

A

B

Dr.T.V.Rao MD 28

Toxin ( Contd )

• Toxin contain two components A 24,000 B 38,000A produce toxigenicity by proteolytic effectB Produce bindingToxin + Formalin = ToxoidWhat is Toxoid – Antigenic, not toxigenicTox + Corynephage Toxin production

Dr.T.V.Rao MD 29

Toxin ( contd )• Need iron 0.1 mg/liter.• Toxin inhibits protein synthesis• Fragment A catalyzes the transfer of ADP ribose from the

Nicotinamide adenine dinucleotide ( NAD ) to the eukaryotic elongation factor 2 /(Fragment A inhibits polypeptide chain elongation in the presence of Nicotinamide adenine dinucleotide by inactivating elongation factor

• Causes involvement with affinity. Myocarditis, Adrenals Nerve endings,

Dr.T.V.Rao MD 30

Antigenic structureAntigenic structure

• Gravis 13,

• Intermedius 4

• Mitis 40

• Bacteriophage typing 15 types

Dr.T.V.Rao MD 31

Resistance Resistance

• Can be killed at

580 c in 10 mt

1000 c in 1 mt

Survive in Blankets, Floor dust, toys inanimate objects

Dr.T.V.Rao MD 32

PathogenicityPathogenicity

• Bacteria Invade, Colonise,Proliferate

• Bacteria are lysogenized by Beta phage

• Produce toxin,

• Kills epithelial and Neutrophils,

• Produce Pharyngitis and cutaneous lesions.

Dr.T.V.Rao MD 33

Pathogenicity Pathogenicity

• Incubation 3 – 4 days / one day

• Faucal / Nasal /Laryngeal / Otic / Conjunctiva,/Genital / Vulvae

Coetaneous

Diphtheria is a toxemic condition.

Malignant Sever toxemia ,Adenitis Bull neck Circulatory failure

Septic Gangrene , pseudo membrane.Dr.T.V.Rao MD 34

Pathogenicity • Hemorrhagic Epistaxis , Purpura General Bleeding tendencyAsphyxia , Acute circulatory failure,Paralysis Pneumonia, Septic shock, Otitis

media. Toxemia, Necrotic changesDeath in Guinea pigs

Dr.T.V.Rao MD 35

Diphtheria• Nasopharyngeal

diphtheria– Pharyngeal – Laryngeal

• Cutaneous diphtheria

• Systemic complications

DIAGNOSIS MUST BE CLINICAL!!!!Dr.T.V.Rao MD 36

Clinical features Clinical features

• Malaise, Sore throat, Fever

• Adherent grey pseudo membrane

• Nasal ulcers,

• Obstruction of larynx and lower airways,

• Difficulty in swallowing

• Lead to Myocarditis, Peripheral neuritis,

• Paralysis of limbs,

Dr.T.V.Rao MD 37

Diphtheria Clinical FeaturesIncubation period 2-5 days

(range, 1-10 days)May involve any mucous membraneClassified based on site of infectionanterior nasalpharyngeal and tonsillarlaryngealcutaneousoculargenital

Dr.T.V.Rao MD 38

Diphtheria Clinical FeaturesDiphtheria Clinical Features

Incubation period 2-5 days (range, 1-10 days)

May involve any mucous membraneClassified based on site of infectionanterior nasalpharyngeal and tonsillarlaryngealcutaneousoculargenital

Dr.T.V.Rao MD 39

Thick MembraneThick Membrane

Dr.T.V.Rao MD 40

Dr.T.V.Rao MD 41

Pseudo membrane

Dr.T.V.Rao MD 42

Skin LesionsSkin Lesions

Dr.T.V.Rao MD 43

Pathogenicity

1 Faucial Diphtheria very common,

• Malignant or Hyper toxic toxemia Marked adenitis, circulatory failure,

• Paralytic sequale

2 Septic ulceration cellulitis, gangrene Epistaxis Bleeding tendency,

Dr.T.V.Rao MD 44

Complications

• Asphyxia - causing mechanical obstruction.

• May need tracheotomy

• Circulatory failure.

• Post Diphtheria paralysis Dr.T.V.Rao MD 45

Non toxigenic clinical Non toxigenic clinical manifestationsmanifestations

• Bacteria can produce

1. Endocarditis,

2.Meingitis,

3 Cerebral abscess.

4 Osteoarthritis.

Dr.T.V.Rao MD 46

Dr.T.V.Rao MD 47

Dr.T.V.Rao MD 48

Laboratory DiagnosisLaboratory Diagnosis

• Specific treatment is more important than Laboratory Diagnosis.

1 Isolation of Diphtheria bacilli.

2.Testing for toxigenicity,

Dr.T.V.Rao MD 49

Collection of Specimens Collection of Specimens

• Throat swabs • Smear examinations Gram s staining, Albert's, PondersImmunoflorescent methodsCultures on Loeffers serum slope Tellurite Blood agar, Blood agar.

Dr.T.V.Rao MD 50

Dr.T.V.Rao MD 51

Isolation of C.diptheria

• Serum slope – Growth in 6 – 8 hours,

• Stain with Neissers stain Albert's stain

• Bacilli have metachromatic granules,

• Tellurite Blood agar takes two days for manifestation of colonies,

Dr.T.V.Rao MD 52

Virulence tests,Virulence tests,• In Vivo and In Vitro• In Vivo in Animals • Subcutaneous tests Inject broth from culture into two Guinea pigs,

0.8 mlOne animal given 500 units of antitoxinOther no Vaccine.Animal not given antitoxin will die Loss of Animals. Restricts its testing.

Dr.T.V.Rao MD 53

Intracutaneous MethodIntracutaneous Method

• One animal given 500 units before toxin

• Other 50 units after Toxin

• So the Animals can be saved

Dr.T.V.Rao MD 54

In Vitro Testing In Vitro Testing

• Elek s Gel precipitation testing

• Filter paper impregnated with Diphtheria antitoxin 1000 Units / ml

• Tested on the horse serum agar

• Positive / Negative /Test strains tested for Immunodiffusion

• Line of precipitation – test positive

• Other methods testing in Tissue cultures.Dr.T.V.Rao MD 55

Toxigenicity Tests

In Vitro Elek test

In Vivo Animal inoculationrabbit skin test-

necrosis

guinea pig challenge test- lethal

low [Fe 2+] induces toxinDr.T.V.Rao MD 56

Dr.T.V.Rao MD 57

Schick TesSchick Test ( Out dated )t ( Out dated )–Schick test: It is an intradermal test,

the test is carried out by injecting intradermally into the skin of forearm 0.2 ml of diphtheria toxin, while into the opposite arm is injected as a control, the same amount of toxin which has been inactivated by heat.

Dr.T.V.Rao MD 58

Interpretation• Negative reaction: If a person had immunity to diphtheria,

no reaction will be observed on either arm.

• Positive reaction: An area of in duration 10-15 mm in diameter generally appears within 24-36 hours reaching its maximum development by 4-7 days, the control arm shows no change. The person is susceptible to diphtheria.

• False positive reaction: A red flush develops in both arms, the reaction fades very quickly, and disappears by 4th day. This is an allergic type of reaction found in certain individuals

• Combined reaction: the control arm shows pseudo positive reaction and the test arm is true +ve reaction, susceptible and need vaccinationDr.T.V.Rao MD 59

Schick TestSchick Test

• Injection of toxin I D

• Produces redness/erythematic in 2-4 days

• No reaction – Protective immunity present.

Dr.T.V.Rao MD 60

Dr.T.V.Rao MD 61

EpidemiologyEpidemiology

• Eradicated in developed nations,

• Children between 2 – 5 years.

• A symptomatic carriers

• Person to person contact.

• Carriers spread.

• Prolonged contact.

Dr.T.V.Rao MD 62

ProphylaxisProphylaxis

• Immunization

• Active – Passive

• Both passive and Active.

• Herd Immunity.

• Schick test

• Immunization with AntitoxinDr.T.V.Rao MD 63

Active Immunization.Active Immunization.• Toxoid – Toxin treated with Formaldehyde • Absorbed Toxoid • Given by Intramuscular route • Given in DTP –Triple Vaccine • Primary Immunization • Three Doses of DPT at least 4 weeks apart.• Non vaccinated • Three doses of Toxoid four weeks apart• One dose after One Year.

Dr.T.V.Rao MD 64

Prevention

Vaccination: Immunisation with diphtheria toxoid, combined with tetanus and pertussis toxoid (DTP vaccine), should be given to all children at two, three and four months of age. Booster doses are given between the ages of 3 and 5 .

The child is given a further booster vaccine before leaving school and is then considered to be protected for a further 10 years (16 – 18 years).

Dr.T.V.Rao MD 65

Passive Immunization

• Given in Acute infections

• Give Subcutaneously

• 500 – 1000 Units of Antitoxin

• Given as Horse Serum

• Combined in Acute Infections ( Both Active Immunization with Toxoid and Antitoxin.

Dr.T.V.Rao MD 66

Treatment Treatment • Antibiotic not useful in Acute infections,• Antitoxin a must.• Anti toxin obtained from horse serum• Mild 20,000 to 40,000• Moderate 40,000 to 60,000• Severe 80,000 to 1,00,000• Commonly used antibiotics,• Penicillin parentally,• Oral Erythromycin

Dr.T.V.Rao MD 67

Diphtheria EpidemiologyDiphtheria EpidemiologyReservoir Human carriers

Usually asymptomatic

Transmission Respiratory Skin and fomites rarely

Temporal pattern Winter and spring

Communicability Up to several weekswithout antibiotics

Dr.T.V.Rao MD 68

Treating ContactsTreating Contacts

• All contacts are advised to receive

500 mg Erythromycin 4 times a day.

Dr.T.V.Rao MD 69

Dr.T.V.Rao MD 70

Other CorynebacteriumOther Corynebacterium

• C.ulcerans

• Like C.diptheria

• Gravis type gelatin liquefied

• Transmitted through cows Milk

• Erythromycin effective.

• Diphtheria antitoxin is protective.Dr.T.V.Rao MD 71

Diptheroids

• Resembles C.diptheria

• Commensals in throat, skin,

• C.hofmani

• C.xerosi

• Propioniebacterium

• P.acnes P.granulosum Dr.T.V.Rao MD 72

• Programme Created by Dr.T.V.Rao Programme Created by Dr.T.V.Rao MD for Medical and Paramedical MD for Medical and Paramedical Students in Developing World Students in Developing World

• Email

• doctortvrao@gmail.com

Dr.T.V.Rao MD 73